Business
Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference
CELEBRATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco, CA on Thursday, January 15, 2026, at 9:45 a.m. PT. Additionally, management will be available for one-on-one meetings with registered c
About this update from Zevra Therapeutics, Inc.
[{"type":"image","alt":"Zevra Therapeutics","displaySize":"","headline":null,"caption":"Zevra Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":80,"url":"https://media.zenfs.com/en/globenewswire.com/47aa28c5ce5943ac0fb423dcc40d01c5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BTrlkcW3K5pHsBf7HqZtVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/47aa28c5ce5943ac0fb423dcc40d01c5","width":300,"height":80}},"lazy":false},{"type":"text","content":"CELEBRATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco, CA on Thursday, January 15, 2026, at 9:45 a.m. PT.","length":415,"tagName":"p"},{"type":"text","content":"Additionally, management will be available for one-on-one meetings with registered conference attendees. A link to the live webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website at investors.zevra.com.","length":268,"tagName":"p"},{"type":"text","content":"About Zevra Therapeutics, Inc.","length":30,"tagName":"p"},{"type":"text","content":"Zevra Therapeutics, Inc. is a purpose-driven, commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases. The company’s commercialization of its lead product, marketed in the U.S. for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disorder, provides a strong corporate foundation and validates its ability to advance therapies. In addition, the company is broadening access through geographic expansion opportunities and has a pipeline of rare disease programs. Zevra is a patient-centric organization guided by our values of accountability, integrity, innovation and courage, with the goal of creating long-term value for patients, partners, and shareholders.","length":735,"tagName":"p"},{"type":"text","content":"For more information, please visit www.zevra.com or follow us on X and LinkedIn.","length":80,"tagName":"p"},{"type":"text","content":"Caution Concerning Forward-Looking Sta...